ArticleBone & joint open2022

HIPGEN: a randomized, multicentre phase III study using intramuscular PLacenta-eXpanded stromal cells therapy for recovery following hip fracture arthroplasty : a study design.

Tobias Winkler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.